1. Abdalla F, Boder J, Markus R, et al. Correlation of nuclear morphometry of breast cancer in histological sections with clinicopathological features and prognosis. Anticancer Res, 2009, 29(5):1771–1776.
2. Martincich L, Deantoni V, Bertotto I, et al. Correlations between diffusion- weighted imaging and breast cancer biomarkers. Eur Radiol, 2012, 22(7):1519-1528.
3. 陈倩, 沈玉英, 陈双庆, 等. 多模态MRI对致密型乳腺中乳腺癌的诊断价值. 实用放射学杂志, 2016, 32(10): 1535-1538.
4. 李丽, 环刘, 万花, 王瑞, 叶媛媛. MRI定量增强参数与乳腺癌预后因子及分子分型的相关性. 中华放射学杂志, 2016, 50 (5): 329-333.
5. 李瑞敏，顾雅佳，彭卫军，毛健. 定量动态增强磁共振评估乳腺癌新辅助化疗疗效的应用研究.中国癌症杂志, 2016, 26(7): 623-628.
6. Thomassinnaggara I, De BC, Chopier J, et al. Diffusion-weighted MR imaging of the breast: Advantages and pitfalls. Eur J Radiol, 2012, 82(3):435-436.
7. Constantini M, Belli P, Rinaldi P, et al. Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness. Clin Radiol , 2010, 65(12):1005-1012.
8. Kamitani T, Matsuo Y, Yabuuchi H, et al. Correlations between apparent diffusion coefficient values and prognostic factors of breast cancer. Magn Reson Med Sci, 2013, 12(3):193-199.
9. Kim SH, Cha ES, Kim HS, et al. Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors. J Magn Reson Imaging, 2009, 30(3):615–620.
10. Park SH, Choi HY, Hahn SY. Correlations between apparent diffusion coefficient values of invasive ductal carcinoma and pathologic factors on diffusion-weighted MRI at 3.0 Tesla. J Magn Reson Imaging, 2015, 41(1):175-182.
11. Razek AA, Gaballa G, Denewer A, Nada N. Invasive ductal carcinoma: correlation of apparent diffusion coefficient value with pathological prognostic factors. NMR Biomed, 2010, 23(6): 619–623.